W. Wilson

发表

The regulation of constitutive NF-κB activity by glycogen synthase kinase-3 in pancreatic cancer

W. Wilson, 2009 .

Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells

J. LoPiccolo, J. Gills, P. Dennis, 2012, Cell Death and Disease.

Rapamycin prevents the development and progression of mutant EGFR lung tumors with the acquired resistance mutation T790M

P. Jänne, W. Pao, P. Dennis, 2014 .

Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription

A. Baldwin, P. Cogswell, W. Wilson, 2005, Molecular and Cellular Biology.

Selecting transpositions using phage P1 headful packaging: new markerless transposons for functionally mapping long-range regulatory sequences in bacterial artificial chromosomes and P1-derived artificial chromosomes.

P. K. Chatterjee, J. Coren, S. Mukherjee, 2004, Analytical biochemistry.

Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

A. Baldwin, P. Cogswell, W. Wilson, 2005, Molecular and cellular biology.

Maintenance of Constitutive I κ B Kinase Activity by Glycogen Synthase Kinase-3 α / β in Pancreatic Cancer

A. Baldwin, W. Wilson, 2009 .

Automated Purification of Dye Terminator Sequencing Reactions: An Approach to High-Throughput Capillary Electrophoresis Sequencing of Large Templates

P. K. Chatterjee, R. Gilmore, W. Wilson, 2003 .

Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.

J. Taube, Q. K. Li, H. Kitagawa, 2016, Cancer research.

Control of PD-L 1 Expression by Oncogenic Activation of the AKT – mTOR Pathway in Non – Small Cell Lung Cancer

J. Taube, Q. K. Li, H. Kitagawa, 2016 .

Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells

J. Berzofsky, T. Whiteside, N. Tarasova, 2016, Cancer Immunology Research.

Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.

A. Baldwin, W. Wilson, 2008, Cancer research.

GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.

J. Yeh, A. Baldwin, W. Wilson, 2013, Cancer discovery.

GSK-3a Promotes Oncogenic KRAS Function in Pancreatic Cancer via TAK1–TAB Stabilization and Regulation of Noncanonical NF-kB

J. Yeh, A. Baldwin, W. Wilson, 2013 .

SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines.

C. Rudin, J. Gills, P. Dennis, 2014, Lung cancer.

Rapamycin prevents the development and progression of mutant epidermal growth factor receptor lung tumors with the acquired resistance mutation T790M.

P. Jänne, W. Pao, Kwok-Kin Wong, 2014, Cell reports.

Flipping the phenotypic switch on a novel antimelanoma differentiation strategy

G. Merlino, W. Wilson, 2013, Pigment cell & melanoma research.

Complex cardiac Nkx2-5 gene expression activated by noggin-sensitive enhancers followed by chamber-specific modules.

R. Schwartz, F. Demayo, P. K. Chatterjee, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15.

T. A. Bell, D. Threadgill, F. Pardo-Manuel de Villena, 2004, Genomics.

Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid.

R. Braun, Rod D Braun, Asad Abbas, 2002, Investigative ophthalmology & visual science.

Abstract 4981: PI3K/AKT/mTOR pathway activation drives expression of the immune inhibitory ligand PD-L1 in NSCLC.

P. Dennis, W. Wilson, Kristin J. Lastwika, 2013 .